Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Graveoline (2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one) is an apoptosis and autophagy inducer in skin melanoma cancer cells
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 50.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 59.00 |
Description | Graveoline (2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one) is an apoptosis and autophagy inducer in skin melanoma cancer cells |
In vitro | Results of MTT assay revealed that, in case of A375 cells,the cell viability gradually decreased upon administration of minimal concentration to the higher ones of graveoline. Upon treatment with 22.23 ± 0.79 μg/mL of graveoline,the cell viability reduced to 50%[1] . |
Synonyms | 2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one, Foliosine |
Molecular Weight | 279.29 |
Formula | C17H13NO3 |
CAS No. | 485-61-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.2 mg/mL (18.62 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Graveoline 485-61-0 Autophagy 2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one Foliosine inhibitor inhibit